SCHEMBL29612043

SCHEMBL29612043

COc1ccc(-c2cc(=O)c3ccc(OC)c(OC)c3o2)cc1OC

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 7/20 0.77
CYP3A4 P08684 4/20 0.72
CYP1A2 P05177 2/20 0.72
CYP2C19 P33261 1/20 0.72
NCOA1 Q15788 1/20 0.72
NCOA3 Q9Y6Q9 1/20 0.72
ABCB1 P08183 5/20 0.69
ABCG2 Q9UNQ0 3/20 0.69
ABCC1 P33527 1/20 0.69
ALDH1A1 P00352 3/20 0.67
MAPT P10636 3/20 0.67
MAPK1 P28482 3/20 0.67
MEN1 O00255 3/20 0.67
KMT2A Q03164 3/20 0.67
KDM4E B2RXH2 2/20 0.67
HPGD P15428 2/20 0.67
HSD17B10 Q99714 2/20 0.67
CYP1A1 P04798 2/20 0.66
CYP1B1 Q16678 2/20 0.66
USP2 O75604 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL988001 1.00 TERT (0.77) TERTCYP3A4CYP1A2CYP2C19NCOA1
SCHEMBL6613755 0.88 TERT (0.77) TERTCYP3A4CYP1A2CYP2C19NCOA1
SCHEMBL16894651 0.88 TUBB4A (0.76) TERTCYP3A4CYP1A2CYP2C19NCOA1
SCHEMBL6612282 0.88 TUBB4A (0.76) TERTCYP3A4CYP1A2CYP2C19NCOA1
SCHEMBL6803148 0.87 TERT (0.80) TERTCYP3A4CYP1A2CYP2C19NCOA1
SCHEMBL6614329 0.87 TERT (1.00) TERTCYP3A4CYP1A2CYP2C19NCOA1
SCHEMBL27381836 0.86 CYP1A2 (0.73) TERTCYP3A4CYP1A2CYP2C19NCOA1
SCHEMBL16704751 0.86 CYP1A1 (0.76) TERTCYP3A4CYP1A2CYP2C19NCOA1
SCHEMBL21647169 0.86 CYP1A2 (0.73) TERTCYP3A4CYP1A2CYP2C19NCOA1
SCHEMBL4649487 0.86 CYP3A4 (0.76) TERTCYP3A4CYP1A2CYP2C19NCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110498784-B Nobiletin derivatives or pharmaceutically acceptable salts thereof, and preparation method and application thereof 广东克冠达医药科技有限公司 2022-06-14 CN disclosed